Aberrant DNA methylation profile of hepatocellular carcinoma and surgically resected margin

Cancer Science

Volumn 100, Issue 6, 2009, Pages 996-1004

  Lou, Cheng ^a   Du, Zhi ^a,b   Yang, Bin ^c   Gao, YingTang ^b   Wang, YiJun ^a   Fang, ShuChang ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Tianjin Key Laboratory of Artificial Cell   (China)

^c NANKAI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; GROWTH INHIBITOR; PROTEIN RIZ1; UNCLASSIFIED DRUG; DNA; HEPATITIS B SURFACE ANTIGEN; PRIMER DNA; RASSF1 PROTEIN, HUMAN; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DNA DETERMINATION; DNA METHYLATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SECOND CANCER; SURVIVAL TIME; DISEASE COURSE; GENETICS; LIVER TUMOR; NUCLEOTIDE SEQUENCE; PATHOLOGY; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; DNA METHYLATION; DNA PRIMERS; DNA, NEOPLASM; FEMALE; GENES, APC; HEPATITIS B SURFACE ANTIGENS; HUMANS; LIVER NEOPLASMS; MALE; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEINS;

EID: 67649870740     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01138.x     Document Type: Article

References (33)

1. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953, 6:963-8.
2. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003, 63:1727-30.
3. Gabriel D, John PJ, Mark AB, Ryan LP. Clinical implications and utility of field cancerization. Cancer Cell Int 2007, 7:2.
4. Wong DJ, Paulson TG, Prevo LJ. P16 (INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. Cancer Res 2001, 61:8284-9.
5. Chang YL, Wu CT, Lin SC, Hsiao CF, Jou YS, Lee YC. Clonality and prognostic implications of p53 and epidermal growth factor receptor somatic aberrations in multiple primary lung cancers. Clin Cancer Res 2007, 13:52-8.
6. Kim SK, Jang HR, Kim JH. The epigenetic silencing of LIMS2 in gastric cancer and its inhibitory effect on cell migration. Biochem Biophys Res Commun 2006, 349:1032-40.
7. Shen L, Kondo Y, Rosner GL. MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst 2005, 97:1330-8.
8. Heaphy CM, Bisoffi M, Fordyce CA. Telomere DNA content and allelic imbalance demonstrate field cancerization in histologically normal tissue adjacent to breast tumors. Int J Cancer 2006, 119:108-16.
9. Das PM, Singal R. DNA Methylation and Cancer. J Clin Oncol 2004, 22:4632-42.
10. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001, 61:3225-9.
11. Sobin LH, Wittekind C. TNM classification of malignant tumors[M] 2002, 81-3. International Union Against Cancer (UICC), eds, 6th edn, New York, Wiley-Liss
12. Yang BH. Clinical staging research on hepatocellular carcinoma. Modern Digestion Intervention 2002, 7:5-7.
13. Yang B, Gao YT, Du Z, Zhao L, Song WQ. Methylation-based molecular margin analysis in hepatocellular carcinoma. Biochem Biophys Res Commun 2005, 338:1353-8.
14. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB, Methylation-specific PCR. A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996, 93:9821-6.
15. Esteller M, Corn PG, Urena JM, Gabrielson E, Baylin SB, Herman JG. Inactivation of glutathione s-transferase P1 gene by promoter hypermethylation in human neoplasia. Cancer Res 1998, 58:4515-8.
16. Lo KW, Kwong J, Hui AB. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res 2001, 61:3877-81.
17. Tsuchiya T, Tamura G, Sato K. Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia. Oncogene 2000, 19:3642-6.
18. Katzenellenbogen RA, Baylin SB, Herman JG. Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. Blood 1999, 93:4347-53.
19. Yoshikawa H, Matsubara K, Qian GS. SOCS-1,a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet 2001, 28:29-35.
20. Du Y, Carling T, Fang W, Piao Z, Sheu JC, Huang S. Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily. Cancer Res 2001, 61:8094-9.
21. Gonzalez-Gomez P, Bello MJ, Lomas J. Aberrant methylation of multiple genes in neuroblastic tumours: relationship with MYCN amplification and allelic status at 1p. Eur J Cancer 2003, 39:1478-85.
22. Nomoto S, Kinoshita T, Kato K. Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma. Br J Cancer 2007, 97:1260-5.
23. Yoshida T, Ogata H, Kamio M. SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis. J Exp Med 2004, 199:1701-7.
24. Paradis V, Laurendeau I, Vidaud M, Bedossa P. Clonal analysis of macronodules in cirrhosis. Hepatology 1998, 28:953-8.
25. Ochiai T, Urata Y, Yamano T, Yamagishi H, Ashihara T. Clonal expansion in evolution of chronic hepatitis to hepatocellular carcinoma as seen at an X-chromosome locus. Hepatology 2000, 31:615-21.
26. Katoh H, Shibata T, Kokubu A. Epigenetic instability and chromosomal instability in hepatocellular carcinoma. Am J Pathol 2006, 168:1375-84.
27. Peng CY, Chen TC, Hung SP. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma. Anticancer Res 2002, 22:1265-71.
28. Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JP. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res 1998, 58:5489-94.
29. Nakamura M, Watanabe T, Yonekawa Y, Kleihues P, Ohgaki H. Promoter methylation of the DNA repair gent MGMT in astrocytomas is frequently associated with G : C - A : T mutations of the TP53 tumor suppressor gene. Carcinogenesis 2001, 22:1715-9.
30. Park TJ, Han SU, Cho YK, Paik WK, Kim YB, Lim IK. Methylation of O (6)-methylguanine-DNA methyltransferase gene is associated significantly with K-ras mutation, lymph node invasion, tumor staging, and disease free survival in patients with gastric carcinoma. Cancer 2001, 92:2760-8.
31. Sakon M, Umeshita K, Nagano H. Clinical significance of hepatic resection in hepatocellular carcinoma: analysis by disease-free survival curves. Arch Surg 2000, 135:1456-9.
32. Braakhuis BJM, Brakenhoff RH, Leemans CR. Second Field Tumors: a new opportunity for cancer prevention?. Oncologist 2005, 10:493-500.
33. Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 2000, 89:500-7.